Committee Composition

Management | Board of Directors | Committee Composition | Governance Documents

Chairman of the Board = Chairman of the Board      Chair = Chair     Committee Member = Member   Independent Director = Independent Director

  Audit Compensation Nominating / Corporate Governance
Leslie A. Blodgett      
Chief Executive Officer

Leslie A. Blodgett has served as Chief Executive Officer of Bare Escentuals and a member of the board of directors of Bare Escentuals and that of its predecessor since 1995. From 1995 until May 2006, Ms. Blodgett also served as President of Bare Escentuals and that of its predecessor. Prior to joining Bare Escentuals, Ms. Blodgett held various positions at Neutrogena, a dermatology division of Johnson & Johnson, a manufacturer of health care products, Procter & Gamble, Inc., a manufacturer and distributor of household products and Max Factor, a cosmetics division of Procter & Gamble. Ms. Blodgett completed the Cosmetic Marketing Program at the Fashion Institute of Technology in New York, New York.

Ross M. Jones Chairman of the Board Independent Director     Committee Chair for Nominating / Corporate Governance Committee
Bradley M. Bloom Independent Director   Committee Chair for Compensation Committee  
Michael R. Egeck Independent Director      
Ellen L. Brothers Independent Director     Member of Nominating / Corporate Governance Committee
John Hamlin Independent Director   Member of Compensation Committee  
Kristina Leslie Independent Director Member of Audit Committee    
Lea Anne Ottinger Independent Director Member of Audit Committee    
Karen M. Rose Independent Director Committee Chair for Audit Committee    
Glen T. Senk Independent Director   Member of Compensation Committee Member of Nominating / Corporate Governance Committee

Stock transaction information provided by EDGAR Online. Bare Escentuals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.